Newborn Screening Market is forecast to Rise at a CAGR of 11.14% during 2014-2023

Industry Outlook and Trend Analysis:
The Newborn Screening Market was worth USD 0.58 billion in 2014 and is expected to reach approximately USD 1.49 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 11.14% during the forecast period.

Developing neonatal populace base, rising instances of congenital diseases in newborns, ideal government programs and enactments, and technological progressions are foreseen to fill in as imperative drivers of the newborn screening market. Rising neonatal populace is one of the key market drivers.

Browse Full Report @ .

To avert this efforts are being taken by associations, for example, the WHO, CDC, Healthy Newborn Network, and so on, to instruct parents for the possible disorders and their indicative procedures. In expansion, government projects and enactments likewise make a positive domain to cultivate market development.

Regional Outlook and Trend Analysis:
North America held the biggest share of the newborn screening market inferable from the developing predominance of congenital disorders and implemented testing in all the 50 conditions of the country. Newborn screening program is diligently followed in every one of the conditions of North America.

Asia Pacific is foreseen to witness lucrative development over the conjecture time frame because of, the existence of good medicinal services plans drafted by government organizations.

Read Premium News from The PR Newswire of Cloud Gaming Market @ .

Data Mining:
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Table of Contents:
2.Executive Summary
3.Market Overview
4.Market Analysis by Regions

4.1.North America (United States, Canada and Mexico)
4.1.1.United States Market States and Outlook (2014-2023)
4.1.2.Canada Market States and Outlook (2014-2023)
4.1.3.Mexico Market States and Outlook (2014-2023)
4.2.Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1.Germany Market States and Outlook (2014-2023)
4.2.2.France Market States and Outlook (2014-2023)
4.2.3.UK Market States and Outlook (2014-2023)
4.2.4.Russia Market States and Outlook (2014-2023)
4.2.5.Italy Market States and Outlook (2014-2023)
4.2.6.Rest of Europe Market States and Outlook (2014-2023)
4.3.Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1.China Market States and Outlook (2014-2023)
4.3.2.Japan Market States and Outlook (2014-2023)
4.3.3.Korea Market States and Outlook (2014-2023)
4.3.4.India Market States and Outlook (2014-2023)
4.3.5.Rest of Asia-Pacific Market States and Outlook (2014-2023)
4.4.South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1.Brazil Market States and Outlook (2014-2023)
4.4.2.Argentina Market States and Outlook (2014-2023)
4.4.3.Columbia Market States and Outlook (2014-2023)
4.4.4.Rest of South America Market States and Outlook (2014-2023)
4.5.Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1.Saudi Arabia Market States and Outlook (2014-2023)
4.5.2.UAE Market States and Outlook (2014-2023)
4.5.3.Egypt Market States and Outlook (2014-2023)
4.5.4.Nigeria Market States and Outlook (2014-2023)
4.5.5.South Africa Market States and Outlook (2014-2023)
4.5.6.Rest of MEA Market States and Outlook (2014-2023)
To be Continued…

Get Sample Copy of This Report @ .

Product Outlook and Trend Analysis:
Instruments used for newborn screening incorporate pulse oximeters, mass spectrometers, fractionators, and others. The instruments market segment is foreseen to encounter development inferable from expanding interest for infant screening over the globe.

Technology Outlook and Trend Analysis:
Tandem mass spectrometry (TMS) is a progressed logical instrument used as a part of the research facilities which can examine body liquids and other body contaminants. Tandem mass spectrometry ruled the general market in 2014 inferable from appeal because of cost adequacy, higher applicability and technological up gradation. Tandem spectroscopy (MS/MS) is foreseen to develop at a tremendous CAGR over the figure time frame, because of its high capacity in diagnosing a variety of conditions in a single procedure.

Test Type Outlook and Trend Analysis:
Dry blood spot tests ruled the general newborn screening market representing more than 45.0% of income. The collection of blood from newborn’s heel area in 24-48 hours of birth on the screening card for analysis of more than 50 conditions is named as heel stick or dried blood spot test (DBS). These screening cards are labeled using different codes and contain no extra identity data. Critical Congenital Heart Disease (CCHD) is one of the normally happening issues, which is screened using the beat oximeter based technology.

Competitive Insights:
The leading players in the market are Natus Medical Incorporated, Masimo, PerkinElmer, Covidien Ltd, Waters Corporation, Trivitron Healthcare, Bio-Rad Laboratories, Wipro GE Healthcare Pvt Ltd and Applied Biosystems/MDS Sciex J.V.

Make an Inquiry @ .

About Crystal Market Research:
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact Us:
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282